Free tool
Diagnostics stocks
We cover 21 companies grouped under the Diagnostics theme. The median market value in the group is $275.63M. Across the group, the median move over the past trading day is +0.07%. 86% of the 21 with a 200-day average trade above it. Price change over the past year runs from −41.5% to +100.0% across the middle 80 percent of the group, with a median of +6.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
21 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| NTRA | Natera, Inc. | $336.71 | +30.49% | +47.14% | +107.24% |
| 0KSX.L | Quest Diagnostics Incorporated | $243.72 | +0.48% | +42.44% | +36.94% |
| LH | Labcorp Holdings Inc. | $337.68 | +12.12% | +34.52% | +23.25% |
| 0JSY.L | Labcorp Holdings Inc. | $334.61 | +1.86% | +33.14% | +20.97% |
| DGX | Quest Diagnostics Incorporated | $244.51 | +5.46% | +41.95% | +38.70% |
| CSTL | Castle Biosciences, Inc. | $35.00 | +43.21% | −9.19% | +70.15% |
| IDX.AX | Integral Diagnostics Limited | 2.40 AUD | +15.38% | −3.07% | −17.78% |
| CEVI.ST | CellaVision AB (publ) | 167.40 SEK | +15.93% | +13.18% | −3.32% |
| ACL.AX | Australian Clinical Labs Limited | 2.89 AUD | +20.42% | +7.73% | +12.06% |
| YDES | YD Bio Ltd | $4.68 | +104.37% | −61.00% | −64.97% |
| 0RAR.L | Stratec SE | 23.05 EUR | +2.67% | +4.06% | −13.37% |
| XGN | Exagen Inc. | $7.60 | +72.73% | +25.83% | −22.84% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | 2,862.00 JPY | +5.84% | +8.96% | +21.25% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| PRPO | Precipio, Inc. | $30.85 | +34.60% | +29.51% | +117.41% |
| RIBB | Ribbon Acquisition Corp. | $10.88 | +0.51% | +4.97% | +6.62% |
| ABDX.L | Abingdon Health Plc | 11.00 GBP | +11.68% | +71.87% | +100.00% |
| RENX.L | Renalytix Plc | 4.25 GBP | +60.38% | −27.97% | −27.35% |
| GSS.AX | Genetic Signatures Limited | 0.08 AUD | +38.33% | −66.12% | −72.33% |
| CNSL.L | Cambridge Nutritional Sciences plc | 1.90 GBP | +8.57% | −2.56% | −41.54% |
| BIAF | bioAffinity Technologies, Inc. | $5.19 | +661.00% | +325.41% | −30.52% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.